Who makes [18F]P16-129?

[18F]P16-129 is developed by Five Eleven Pharma, Inc..

Last reviewed 2026-04-19 · How we verify

[18F]P16-129

Five Eleven Pharma, Inc. · Phase 1 active Small molecule

At a glance

Generic name	[18F]P16-129
Also known as	[18F]D3FSP
Sponsor	Five Eleven Pharma, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]P16-129 CI brief — competitive landscape report
[18F]P16-129 updates RSS · CI watch RSS
Five Eleven Pharma, Inc. portfolio CI